Most Recent Articles by Virginia Schad
Glecaprevir plus pibrentasvir treatment results in high sustained virologic response rates irrespective of viral characteristics.
Future studies might focus on the use of electronic medical record warning systems or other prompts to improve diagnostic test use in at-risk individuals.
Discontinuing methotrexate for 2 weeks following flu vaccine may improve the immunogenicity of the vaccine in patients with rheumatoid arthritis.
A population cohort study evaluated the effects of chronic hepatitis B infection on mortality rates of people infected with acute hepatitis E.
Although some regions are well on their way to meeting prophylaxis and prevalence targets, all regions must substantially scale-up access to diagnosis and treatment to meet the global targets.
More Articles by Virginia Schad
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Generic HIV Medicines: Boon or Bust?
- Insulin-Treated Diabetes Reduces Dysglycemia-Related Mortality in Sepsis
- Pregnancy May Be Independently Associated With Prolonged Detection of Zika Virus RNA
- It Costs $2.2 Billion a Year to Treat Antibiotic Resistance
- Tricyclic Antidepressants May Reduce Cirrhosis Risk in Hepatitis C
- Fingerstick Point-of-Care Test Allows for Single-Visit HCV Diagnoses
- Clostridium difficile Infection in the Intensive Care Setting
- Combating Medically Important Antibiotic Use in Food-Producing Animals
- Religious Exemptions vs Mandatory Vaccinations: An Expert Perspective
- 2018 Vaccination Schedule: Adults
- Efficacy of Adjuvanted vs Conventional Quadrivalent Flu Vaccine Compared
- Glecaprevir/Pibrentasvir Highly Efficacious for HCV/HIV Coinfection
- Fluoroquinolone Use May Increase Risk for Aortic Aneurysm and Dissection
- Reduced Risk of Hepatocellular Carcinoma in DAA-Treated HCV Infection
- Paracetamol Overuse During Cold and Flu Season